Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Cash (2019 - 2025)

Historic Change in Cash for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to -$931000.0.

  • Outset Medical's Change in Cash fell 10102.62% to -$931000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$88.5 million, marking a year-over-year decrease of 25945.95%. This contributed to the annual value of -$88.5 million for FY2025, which is 25945.95% down from last year.
  • According to the latest figures from Q4 2025, Outset Medical's Change in Cash is -$931000.0, which was down 10102.62% from -$3.1 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's Change in Cash ranged from a high of $90.7 million in Q4 2024 and a low of -$68.0 million during Q1 2022
  • Moreover, its 5-year median value for Change in Cash was -$16.1 million (2022), whereas its average is -$14.5 million.
  • The largest annual percentage gain for Outset Medical's Change in Cash in the last 5 years was 2831500.0% (2024), contrasted with its biggest fall of 492417.58% (2024).
  • Over the past 5 years, Outset Medical's Change in Cash (Quarter) stood at -$48.2 million in 2021, then surged by 57.11% to -$20.7 million in 2022, then skyrocketed by 255.95% to $32.2 million in 2023, then surged by 181.66% to $90.7 million in 2024, then plummeted by 101.03% to -$931000.0 in 2025.
  • Its Change in Cash stands at -$931000.0 for Q4 2025, versus -$3.1 million for Q3 2025 and -$36.4 million for Q2 2025.